Thursday, November 19th, 2020 - The Insight Partners

The "Global Asthma Therapeutics Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Asthma therapeutics market with detailed market segmentation by product type, drug class, route of administration and geography. The global asthma therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Asthma therapeutics market players and offers key trends and opportunities in the market.

The environmental factors include exposure to air pollution, pollen grains and allergens. The pulmonary airway muscles get swollen due to allergens, which cause bronchospasm and airway obstruction. Patients with genetic history of asthma are more prone to developing asthma. Asthma can be controlled by early asthma treatment. The medications include long acting beta-agonists (LABA), corticosteroids, anti-inflammatory agents and leukotriene modifiers. Asthma patients are always at risk of developing with pneumonia and influenza. Asthma mimicking symptoms have been found in a host of diseases in children. Hence, diagnosis and treatment of asthma in children has remained a challenge.

Download sample PDF Copy @

According to the Global Initiative for Asthma (GINA), in 2013, 300 million patients globally were reported to be afflicted with asthma and the number is expected to grow in the coming years.

In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

Teva Pharmaceutical Industries Ltd.

Merck KGaA

GlaxoSmithKline Plc

F. Hoffmann La-Roche Ltd.

AstraZeneca Plc

Boehringer Ingelheim GmbH

Sanofi SA

Sunovion Pharmaceuticals, Inc.

CareFusion Corporation

The global asthma therapeutics market is segmented on the basis of product type, drug class and route of administration. Based on products type, the market is segmented as dry powder inhalers, metered dose inhalers, mist inhalers and nebulizer. On the basis of drug class, the global asthma therapeutics market is segmented into anti-inflammatory drugs, bronchodilators and combination therapy. Based on route of administration, the market segmented into oral, inhaled, intravenous and subcutaneous.

Increasing amount of pollution especially children making their immune system weak and sensitive, growing number of smokers and frequent lifestyle changes are the major driving factors for asthma therapeutics market. Thus, various governments are taking initiatives to create awareness amongst people about asthma and related diseases.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global asthma therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The asthma therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Asthma therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Asthma therapeutics market in these regions.

Purchase This Report at:

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:

Call: +1-646-491-9876

Email: [email protected]

Contact Profile

The Insight Partners

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Sameer Joshi
P: +1-646-491-9876


Asthma is a chronic disease which shows various symptoms such as coughing, wheezing, chest tightness and breath shortness. Asthma is caused by environmental and genetic factors.




More Formats

View QR Code